======= TFEB ======= == Gene Information == * **Official Symbol**: TFEB * **Official Name**: transcription factor EB * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7942|7942]] * **UniProt**: [[https://www.uniprot.org/uniprot/P19484|P19484]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TFEB&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TFEB|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600744|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription factor that specifically recognizes and binds E-box sequences (5'-CANNTG-3'). Efficient DNA-binding requires dimerization with itself or with another MiT/TFE family member such as TFE3 or MITF. In association with TFE3, activates the expression of CD40L in T-cells, thereby playing a role in T- cell-dependent antibody responses in activated CD4(+) T-cells and thymus-dependent humoral immunity. Specifically recognizes and binds the CLEAR-box sequence (5'-GTCACGTGAC-3') present in the regulatory region of many lysosomal genes, leading to activate their expression. It thereby plays a central role in expression of lysosomal genes. Acts as a positive regulator of autophagy by promoting expression of genes involved in autophagy. Specifically recognizes the gamma-E3 box, a subset of E-boxes, present in the heavy-chain immunoglobulin enhancer. Plays a role in the signal transduction processes required for normal vascularization of the placenta. {ECO:0000269|PubMed:19556463, ECO:0000269|PubMed:23434374}. |DUF3371| |HLH| |lysosome localization| |lytic vacuole organization| |lysosome organization| |embryonic placenta development| |positive regulation of autophagy| |vacuole organization| |placenta development| |protein dimerization activity| |transcription regulatory region DNA binding| |autophagy| |process utilizing autophagic mechanism| |regulation of autophagy| |humoral immune response| |positive regulation of cellular catabolic process| |in utero embryonic development| |reproductive structure development| |reproductive system development| |positive regulation of catabolic process| |embryonic organ development| |organelle localization| |adaptive immune response| |chordate embryonic development| |embryo development ending in birth or egg hatching| |developmental process involved in reproduction| |DNA-binding transcription factor activity| |regulation of cellular catabolic process| |embryo development| |regulation of catabolic process| |positive regulation of transcription by RNA polymerase II| |reproductive process| |reproduction| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |cellular catabolic process| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp210|LB-100 2μM R05 exp210]]|-1.89| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-1.88| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.86| |[[:results:exp359|FK-506 30μM R07 exp359]]|-1.85| |[[:results:exp70|INK128 0.2μM R02 exp70]]|-1.81| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.8| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.79| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-1.78| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-1.74| |[[:results:exp484|GSK-J5 1.5μM R08 exp484]]|-1.73| |[[:results:exp486|Heregulin-B 44ng/ml R08 exp486]]|-1.73| |[[:results:exp67|BVD-523 15μM R02 exp67]]|1.89| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|1.99| |[[:results:exp155|UNC1999 2μM R03 exp155]]|2.13| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7589 * **Expression level (log2 read counts)**: 4.0 {{:chemogenomics:nalm6 dist.png?nolink |}}